Guideline decision tool · Radiology
🫀

CT Hepatic Steatosis & Spleen Volume (L−S, L/S, Prassopoulos) — free guideline decision tool

Unenhanced liver and spleen HU give L−S and L/S with a steatosis cue; spleen diameters give splenic index and estimated volume. Instant, browser-side.

Open guideline tool →
Computed locally — no data uploaded. For licensed clinicians.
📋

Guideline-based

Implements the decision logic from published clinical guidelines.

🖥️

Runs in your browser

No installation. Enter the patient's values and get a guideline recommendation instantly.

🔒

Data stays local

Nothing is uploaded. Results are for licensed clinicians only.

Worked calculation

The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.

Liver HU (unenhanced, mean of ROIs)38 HU
Spleen HU (unenhanced)50 HU
Spleen length (craniocaudal)11 cm
Spleen width (max axial)9 cm
Spleen thickness (at hilum)4 cm

→L−S-12HU

  • Liver:38 HU — Liver <40 HU: moderate-to-severe steatosis (≥30%) likely
  • L−S:-12 HU (< −10 HU: moderate-to-severe steatosis)
  • L/S:0.76 (<1.0: steatosis)

Common questions

What is CT Hepatic Steatosis & Spleen Volume (L−S, L/S, Prassopoulos)?

Unenhanced liver and spleen HU give L−S and L/S with a steatosis cue; spleen diameters give splenic index and estimated volume. Instant, browser-side.

How is CT Hepatic Steatosis & Spleen Volume (L−S, L/S, Prassopoulos) calculated? What is the core formula?

L−S = liver HU − spleen HU; L/S = liver HU / spleen HU; spleen volume (mL) = 30 + 0.58 × L × W × T (cm, Prassopoulos).

When is CT Hepatic Steatosis & Spleen Volume (L−S, L/S, Prassopoulos) used?

Quantifying fatty liver and splenomegaly on abdominal CT reports.

What are the key clinical points for CT Hepatic Steatosis & Spleen Volume (L−S, L/S, Prassopoulos)?

Liver <40 HU suggests ≥30% steatosis. L−S < −10 HU equivalent. L/S <1.0 suggests steatosis. Spleen length >13 cm suggests splenomegaly.

What are the limits and cautions when using CT Hepatic Steatosis & Spleen Volume (L−S, L/S, Prassopoulos)?

For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.

Does CT Hepatic Steatosis & Spleen Volume (L−S, L/S, Prassopoulos) upload patient data? Where is it calculated?

Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.

How is CT Hepatic Steatosis & Spleen Volume (L−S, L/S, Prassopoulos) calculated in practice? Can you show a worked example?

Inputs: Liver HU (unenhanced, mean of ROIs) 38 HU, Spleen HU (unenhanced) 50 HU, Spleen length (craniocaudal) 11 cm, Spleen width (max axial) 9 cm, Spleen thickness (at hilum) 4 cm → Result: L−S -12 HU(Liver: 38 HU — Liver <40 HU: moderate-to-severe steatosis (≥30%) likely, L−S: -12 HU (< −10 HU: moderate-to-severe steatosis), L/S: 0.76 (<1.0: steatosis))

🫀

Run CT Hepatic Steatosis & Spleen Volume (L−S, L/S, Prassopoulos) now

Unenhanced liver and spleen HU give L−S and L/S with a steatosis cue; spleen diameters give splenic index and estimated volume. Instant, browser-side.

Open guideline tool →

For licensed clinicians. Not a substitute for clinical judgement.

Share on XLinkedInWhatsAppEmail

Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.

Related guideline tools

For use by licensed clinicians and clinical researchers. Computed locally in your browser — no data is uploaded. Not a substitute for clinical judgement.

Water does not race to be first — it strives only to flow on, unbroken

Yuan Doctor
Tertiary-hospital clinical team · local compute · no upload
© 2026 Yuan Doctor · www.yuandoctor.com · Developed & reviewed by a tertiary-hospital clinical team